Insider Selling: Hill-Rom Holdings, Inc. (HRC) SVP Sells 15,000 Shares of Stock
Hill-Rom Holdings, Inc. (NYSE:HRC) SVP Alton Shader sold 15,000 shares of the company’s stock in a transaction dated Thursday, March 16th. The stock was sold at an average price of $69.34, for a total transaction of $1,040,100.00. Following the completion of the sale, the senior vice president now directly owns 52,638 shares of the company’s stock, valued at $3,649,918.92. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
Shares of Hill-Rom Holdings, Inc. (NYSE:HRC) traded down 0.31% during trading on Monday, hitting $69.85. 544,601 shares of the company traded hands. Hill-Rom Holdings, Inc. has a 52-week low of $46.13 and a 52-week high of $70.30. The stock has a market capitalization of $4.56 billion, a PE ratio of 32.53 and a beta of 1.20. The company has a 50-day moving average of $64.16 and a 200-day moving average of $59.40.
Hill-Rom Holdings (NYSE:HRC) last released its earnings results on Friday, January 27th. The medical technology company reported $0.75 earnings per share for the quarter, meeting the consensus estimate of $0.75. The company earned $637.40 million during the quarter, compared to the consensus estimate of $654.12 million. Hill-Rom Holdings had a return on equity of 19.12% and a net margin of 5.44%. Hill-Rom Holdings’s revenue was down 3.7% compared to the same quarter last year. During the same period in the previous year, the company posted $0.68 EPS. Equities analysts expect that Hill-Rom Holdings, Inc. will post $3.81 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Friday, March 31st. Shareholders of record on Friday, March 24th will be given a $0.18 dividend. This is an increase from Hill-Rom Holdings’s previous quarterly dividend of $0.17. This represents a $0.72 annualized dividend and a yield of 1.03%. The ex-dividend date is Wednesday, March 22nd. Hill-Rom Holdings’s payout ratio is currently 31.78%.
Your IP Address:
A number of analysts recently weighed in on the stock. Zacks Investment Research lowered shares of Hill-Rom Holdings from a “buy” rating to a “hold” rating in a research note on Thursday, February 2nd. Barclays PLC started coverage on shares of Hill-Rom Holdings in a research note on Wednesday, February 8th. They issued an “overweight” rating and a $70.00 price objective for the company. Finally, Stifel Nicolaus started coverage on shares of Hill-Rom Holdings in a research report on Monday, January 23rd. They set a “buy” rating and a $70.00 price target for the company. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $65.14.
A number of institutional investors have recently added to or reduced their stakes in the stock. Norges Bank purchased a new position in Hill-Rom Holdings during the fourth quarter valued at $36,707,000. Victory Capital Management Inc. increased its position in Hill-Rom Holdings by 58.6% in the third quarter. Victory Capital Management Inc. now owns 634,549 shares of the medical technology company’s stock valued at $39,330,000 after buying an additional 234,415 shares in the last quarter. Cornerstone Capital Management Holdings LLC. increased its position in Hill-Rom Holdings by 257.3% in the third quarter. Cornerstone Capital Management Holdings LLC. now owns 319,507 shares of the medical technology company’s stock valued at $19,802,000 after buying an additional 230,076 shares in the last quarter. Bogle Investment Management L P DE purchased a new position in Hill-Rom Holdings during the fourth quarter valued at $12,698,000. Finally, Prudential PLC increased its position in Hill-Rom Holdings by 43.7% in the fourth quarter. Prudential PLC now owns 674,000 shares of the medical technology company’s stock valued at $37,838,000 after buying an additional 205,100 shares in the last quarter. 83.53% of the stock is owned by institutional investors.
About Hill-Rom Holdings
Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.
Receive News & Ratings for Hill-Rom Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.